<DOC>
	<DOC>NCT00598728</DOC>
	<brief_summary>The purpose of this study is to collect information on the long-term side effects of treatment for Hodgkin Lymphoma. We hope to study about 500-800 survivors of Hodgkin Lymphoma. We plan to use the findings from this study to better understand Hodgkin Lymphoma survivors' health and quality of life.</brief_summary>
	<brief_title>Quality of Life Among Survivors of Hodgkin Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>Biopsyproven HL Participation in IRBapproved protocols for the firstline treatment of HL between 19752000 (IRB #75104, #75103, #7917, #81103, #9044, #9169). English speaking</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Survivors</keyword>
	<keyword>Quality of Life</keyword>
</DOC>